Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, United States.
Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, United States.
Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):21. doi: 10.1167/iovs.64.14.21.
To apply adaptive optics-optical coherence tomography (AO-OCT) to quantify multiple sclerosis (MS)-induced changes in axonal bundles in the macular nerve fiber layer, ganglion cell somas, and macrophage-like cells at the vitreomacular interface.
We used AO-OCT imaging in a pilot study of MS participants (n = 10), including those without and with a history of optic neuritis (ON, n = 4), and healthy volunteers (HV, n = 9) to reveal pathologic changes to inner retinal cells and structures affected by MS.
We found that nerve fiber layer axonal bundles had 38% lower volume in MS participants (1.5 × 10-3 mm3) compared to HVs (2.4 × 10-3 mm3; P < 0.001). Retinal ganglion cell (RGC) density was 51% lower in MS participants (12.3 cells/mm2 × 1000) compared to HVs (25.0 cells/mm2 × 1000; P < 0.001). Spatial differences across the macula were observed in RGC density. RGC diameter was 15% higher in MS participants (11.7 µm) compared to HVs (10.1 µm; P < 0.001). A nonsignificant trend of higher density of macrophage-like cells in MS eyes was also observed. For all AO-OCT measures, outcomes were worse for MS participants with a history of ON compared to MS participants without a history of ON. AO-OCT measures were associated with key visual and physical disabilities in the MS cohort.
Our findings demonstrate the utility of AO-OCT for highly sensitive and specific detection of neurodegenerative changes in MS. Moreover, the results shed light on the mechanisms that underpin specific neuronal pathology that occurs when MS attacks the retina. The new findings support the further development of AO-based biomarkers for MS.
应用自适应光学-光学相干断层扫描(AO-OCT)定量测量多发性硬化(MS)引起的黄斑神经纤维层、神经节细胞体和玻璃体内膜界面巨噬细胞样细胞内的轴突束的变化。
我们使用 AO-OCT 成像对 MS 参与者(n=10)进行了一项试点研究,包括没有和有视神经炎(ON)病史的参与者(n=4)和健康志愿者(HV,n=9),以揭示受 MS 影响的内视网膜细胞和结构的病理变化。
我们发现 MS 参与者的神经纤维层轴突束体积减少了 38%(1.5×10-3mm3),而 HV 为 2.4×10-3mm3(P<0.001)。MS 参与者的视网膜神经节细胞(RGC)密度降低了 51%(12.3 个细胞/mm2×1000),HV 为 25.0 个细胞/mm2×1000(P<0.001)。RGC 密度在黄斑区存在空间差异。MS 参与者的 RGC 直径增加了 15%(11.7μm),HV 为 10.1μm(P<0.001)。还观察到 MS 眼中巨噬细胞样细胞密度升高的趋势不明显。对于所有的 AO-OCT 测量结果,有 ON 病史的 MS 参与者的结果比没有 ON 病史的 MS 参与者差。AO-OCT 测量结果与 MS 队列的主要视觉和身体残疾相关。
我们的研究结果表明,AO-OCT 对于高度敏感和特异性检测 MS 中的神经退行性变化非常有用。此外,这些结果揭示了 MS 攻击视网膜时发生特定神经元病理的潜在机制。新的发现支持进一步开发基于 AO 的 MS 生物标志物。